Anti-Restenotic Drug Delivery with the AGENT Drug-Coated Balloon: Interview with Dr. Ian Meredith, Global CMO, Boston Scientific
Boston Scientific recently announced a clinical trial of its AGENT drug coated balloon. The device is coated with paclitaxel, an anti-restenotic drug, and aims to deliver the medication to the affected vessel wall during a percutaneous procedure. Cor...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Radiology Vascular Surgery Source Type: blogs
More News: Angioplasty | Baloon Angioplasty | Clinical Trials | Coronary Angioplasty | Heart Attack | Medical Devices | Nanotechnology | Radiation Therapy | Radiology | Study